Vanguard Group Inc. Boosts Stock Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Vanguard Group Inc. lifted its holdings in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 7.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,689,396 shares of the company’s stock after acquiring an additional 784,818 shares during the period. Vanguard Group Inc. owned 2.79% of LifeStance Health Group worth $78,781,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Blue Trust Inc. lifted its position in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after buying an additional 2,122 shares during the last quarter. LPL Financial LLC lifted its position in LifeStance Health Group by 6.0% in the fourth quarter. LPL Financial LLC now owns 37,584 shares of the company’s stock valued at $277,000 after acquiring an additional 2,127 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in LifeStance Health Group by 10.5% in the third quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock valued at $572,000 after acquiring an additional 7,798 shares in the last quarter. Rhumbline Advisers grew its holdings in shares of LifeStance Health Group by 4.5% during the fourth quarter. Rhumbline Advisers now owns 195,581 shares of the company’s stock worth $1,441,000 after purchasing an additional 8,487 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of LifeStance Health Group by 0.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,113,499 shares of the company’s stock valued at $8,206,000 after purchasing an additional 9,046 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Price Performance

Shares of LFST opened at $6.77 on Friday. The firm has a market capitalization of $2.60 billion, a PE ratio of -26.04 and a beta of 1.30. The stock’s 50 day moving average is $7.30 and its two-hundred day moving average is $7.33. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $8.61. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. KeyCorp initiated coverage on LifeStance Health Group in a report on Tuesday. They issued an “overweight” rating and a $9.00 price objective for the company. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective on the stock in a research note on Monday, December 16th. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. Finally, Canaccord Genuity Group initiated coverage on LifeStance Health Group in a research report on Thursday, April 3rd. They issued a “buy” rating and a $8.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $8.58.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the firm’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the sale, the insider now owns 339,810 shares of the company’s stock, valued at approximately $2,344,689. This trade represents a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 6.60% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.